Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants

Clinical trial NCT06753955 · COMPLETED

Trial details

NCT number: NCT06753955
Sponsor: Arialys Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)Autoimmune Encephalitis

Start date: 2025-02-25
Primary completion: 2025-07-02
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.